Global Artificial Intelligence Drug R&D Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.
LPI (LP Information)' newest research report, the “Artificial Intelligence Drug R&D Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Drug R&D sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Drug R&D sales for 2023 through 2029. With Artificial Intelligence Drug R&D sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Drug R&D industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Drug R&D landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Intelligence Drug R&D portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Drug R&D market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Drug R&D and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Drug R&D.
The global Artificial Intelligence Drug R&D market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Artificial Intelligence Drug R&D is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artificial Intelligence Drug R&D is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artificial Intelligence Drug R&D is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artificial Intelligence Drug R&D players cover IBM Watson, BioXel, Insilico Medicine, Gatehouse Bio, Google DeepMind, Genpact Cora, Cyclica Inc, QuantumBlack and Nq Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug R&D market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Artificial Intelligence Drug R&D means that we use AI (narrow AI for now, which specilizing in few tasks) to generate and analyse immense amounts of biological and outcomes data from patients or chem database to predict new targets, or to conclude standard models.
LPI (LP Information)' newest research report, the “Artificial Intelligence Drug R&D Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Drug R&D sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Drug R&D sales for 2023 through 2029. With Artificial Intelligence Drug R&D sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Drug R&D industry.
This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Drug R&D landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Intelligence Drug R&D portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Drug R&D market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Drug R&D and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Drug R&D.
The global Artificial Intelligence Drug R&D market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Artificial Intelligence Drug R&D is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Artificial Intelligence Drug R&D is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Artificial Intelligence Drug R&D is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Artificial Intelligence Drug R&D players cover IBM Watson, BioXel, Insilico Medicine, Gatehouse Bio, Google DeepMind, Genpact Cora, Cyclica Inc, QuantumBlack and Nq Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Drug R&D market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- AI Platfrom
- Analytics Service
- Drug Discovery
- Precision Medicine
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IBM Watson
- BioXel
- Insilico Medicine
- Gatehouse Bio
- Google DeepMind
- Genpact Cora
- Cyclica Inc
- QuantumBlack
- Nq Medical
- Phenomic AI
- Palantir Technologies
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug R&D Market Size 2018-2029
2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Artificial Intelligence Drug R&D Segment by Type
2.2.1 AI Platfrom
2.2.2 Analytics Service
2.3 Artificial Intelligence Drug R&D Market Size by Type
2.3.1 Artificial Intelligence Drug R&D Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
2.4 Artificial Intelligence Drug R&D Segment by Application
2.4.1 Drug Discovery
2.4.2 Precision Medicine
2.5 Artificial Intelligence Drug R&D Market Size by Application
2.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
3 ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE BY PLAYER
3.1 Artificial Intelligence Drug R&D Market Size Market Share by Players
3.1.1 Global Artificial Intelligence Drug R&D Revenue by Players (2018-2023)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE DRUG R&D BY REGIONS
4.1 Artificial Intelligence Drug R&D Market Size by Regions (2018-2023)
4.2 Americas Artificial Intelligence Drug R&D Market Size Growth (2018-2023)
4.3 APAC Artificial Intelligence Drug R&D Market Size Growth (2018-2023)
4.4 Europe Artificial Intelligence Drug R&D Market Size Growth (2018-2023)
4.5 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Artificial Intelligence Drug R&D Market Size by Country (2018-2023)
5.2 Americas Artificial Intelligence Drug R&D Market Size by Type (2018-2023)
5.3 Americas Artificial Intelligence Drug R&D Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug R&D Market Size by Region (2018-2023)
6.2 APAC Artificial Intelligence Drug R&D Market Size by Type (2018-2023)
6.3 APAC Artificial Intelligence Drug R&D Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D by Country (2018-2023)
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2018-2023)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence Drug R&D by Region (2018-2023)
8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2018-2023)
8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET FORECAST
10.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2024-2029)
10.1.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2024-2029)
10.1.2 Americas Artificial Intelligence Drug R&D Forecast
10.1.3 APAC Artificial Intelligence Drug R&D Forecast
10.1.4 Europe Artificial Intelligence Drug R&D Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast
10.2 Americas Artificial Intelligence Drug R&D Forecast by Country (2024-2029)
10.2.1 United States Artificial Intelligence Drug R&D Market Forecast
10.2.2 Canada Artificial Intelligence Drug R&D Market Forecast
10.2.3 Mexico Artificial Intelligence Drug R&D Market Forecast
10.2.4 Brazil Artificial Intelligence Drug R&D Market Forecast
10.3 APAC Artificial Intelligence Drug R&D Forecast by Region (2024-2029)
10.3.1 China Artificial Intelligence Drug R&D Market Forecast
10.3.2 Japan Artificial Intelligence Drug R&D Market Forecast
10.3.3 Korea Artificial Intelligence Drug R&D Market Forecast
10.3.4 Southeast Asia Artificial Intelligence Drug R&D Market Forecast
10.3.5 India Artificial Intelligence Drug R&D Market Forecast
10.3.6 Australia Artificial Intelligence Drug R&D Market Forecast
10.4 Europe Artificial Intelligence Drug R&D Forecast by Country (2024-2029)
10.4.1 Germany Artificial Intelligence Drug R&D Market Forecast
10.4.2 France Artificial Intelligence Drug R&D Market Forecast
10.4.3 UK Artificial Intelligence Drug R&D Market Forecast
10.4.4 Italy Artificial Intelligence Drug R&D Market Forecast
10.4.5 Russia Artificial Intelligence Drug R&D Market Forecast
10.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast by Region (2024-2029)
10.5.1 Egypt Artificial Intelligence Drug R&D Market Forecast
10.5.2 South Africa Artificial Intelligence Drug R&D Market Forecast
10.5.3 Israel Artificial Intelligence Drug R&D Market Forecast
10.5.4 Turkey Artificial Intelligence Drug R&D Market Forecast
10.5.5 GCC Countries Artificial Intelligence Drug R&D Market Forecast
10.6 Global Artificial Intelligence Drug R&D Forecast by Type (2024-2029)
10.7 Global Artificial Intelligence Drug R&D Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 IBM Watson
11.1.1 IBM Watson Company Information
11.1.2 IBM Watson Artificial Intelligence Drug R&D Product Offered
11.1.3 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 IBM Watson Main Business Overview
11.1.5 IBM Watson Latest Developments
11.2 BioXel
11.2.1 BioXel Company Information
11.2.2 BioXel Artificial Intelligence Drug R&D Product Offered
11.2.3 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BioXel Main Business Overview
11.2.5 BioXel Latest Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Information
11.3.2 Insilico Medicine Artificial Intelligence Drug R&D Product Offered
11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Insilico Medicine Main Business Overview
11.3.5 Insilico Medicine Latest Developments
11.4 Gatehouse Bio
11.4.1 Gatehouse Bio Company Information
11.4.2 Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Gatehouse Bio Main Business Overview
11.4.5 Gatehouse Bio Latest Developments
11.5 Google DeepMind
11.5.1 Google DeepMind Company Information
11.5.2 Google DeepMind Artificial Intelligence Drug R&D Product Offered
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Google DeepMind Main Business Overview
11.5.5 Google DeepMind Latest Developments
11.6 Genpact Cora
11.6.1 Genpact Cora Company Information
11.6.2 Genpact Cora Artificial Intelligence Drug R&D Product Offered
11.6.3 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Genpact Cora Main Business Overview
11.6.5 Genpact Cora Latest Developments
11.7 Cyclica Inc
11.7.1 Cyclica Inc Company Information
11.7.2 Cyclica Inc Artificial Intelligence Drug R&D Product Offered
11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Cyclica Inc Main Business Overview
11.7.5 Cyclica Inc Latest Developments
11.8 QuantumBlack
11.8.1 QuantumBlack Company Information
11.8.2 QuantumBlack Artificial Intelligence Drug R&D Product Offered
11.8.3 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 QuantumBlack Main Business Overview
11.8.5 QuantumBlack Latest Developments
11.9 Nq Medical
11.9.1 Nq Medical Company Information
11.9.2 Nq Medical Artificial Intelligence Drug R&D Product Offered
11.9.3 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Nq Medical Main Business Overview
11.9.5 Nq Medical Latest Developments
11.10 Phenomic AI
11.10.1 Phenomic AI Company Information
11.10.2 Phenomic AI Artificial Intelligence Drug R&D Product Offered
11.10.3 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Phenomic AI Main Business Overview
11.10.5 Phenomic AI Latest Developments
11.11 Palantir Technologies
11.11.1 Palantir Technologies Company Information
11.11.2 Palantir Technologies Artificial Intelligence Drug R&D Product Offered
11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Palantir Technologies Main Business Overview
11.11.5 Palantir Technologies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artificial Intelligence Drug R&D Market Size 2018-2029
2.1.2 Artificial Intelligence Drug R&D Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Artificial Intelligence Drug R&D Segment by Type
2.2.1 AI Platfrom
2.2.2 Analytics Service
2.3 Artificial Intelligence Drug R&D Market Size by Type
2.3.1 Artificial Intelligence Drug R&D Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
2.4 Artificial Intelligence Drug R&D Segment by Application
2.4.1 Drug Discovery
2.4.2 Precision Medicine
2.5 Artificial Intelligence Drug R&D Market Size by Application
2.5.1 Artificial Intelligence Drug R&D Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
3 ARTIFICIAL INTELLIGENCE DRUG R&D MARKET SIZE BY PLAYER
3.1 Artificial Intelligence Drug R&D Market Size Market Share by Players
3.1.1 Global Artificial Intelligence Drug R&D Revenue by Players (2018-2023)
3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence Drug R&D Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE DRUG R&D BY REGIONS
4.1 Artificial Intelligence Drug R&D Market Size by Regions (2018-2023)
4.2 Americas Artificial Intelligence Drug R&D Market Size Growth (2018-2023)
4.3 APAC Artificial Intelligence Drug R&D Market Size Growth (2018-2023)
4.4 Europe Artificial Intelligence Drug R&D Market Size Growth (2018-2023)
4.5 Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Artificial Intelligence Drug R&D Market Size by Country (2018-2023)
5.2 Americas Artificial Intelligence Drug R&D Market Size by Type (2018-2023)
5.3 Americas Artificial Intelligence Drug R&D Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artificial Intelligence Drug R&D Market Size by Region (2018-2023)
6.2 APAC Artificial Intelligence Drug R&D Market Size by Type (2018-2023)
6.3 APAC Artificial Intelligence Drug R&D Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artificial Intelligence Drug R&D by Country (2018-2023)
7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2018-2023)
7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artificial Intelligence Drug R&D by Region (2018-2023)
8.2 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2018-2023)
8.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTIFICIAL INTELLIGENCE DRUG R&D MARKET FORECAST
10.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2024-2029)
10.1.1 Global Artificial Intelligence Drug R&D Forecast by Regions (2024-2029)
10.1.2 Americas Artificial Intelligence Drug R&D Forecast
10.1.3 APAC Artificial Intelligence Drug R&D Forecast
10.1.4 Europe Artificial Intelligence Drug R&D Forecast
10.1.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast
10.2 Americas Artificial Intelligence Drug R&D Forecast by Country (2024-2029)
10.2.1 United States Artificial Intelligence Drug R&D Market Forecast
10.2.2 Canada Artificial Intelligence Drug R&D Market Forecast
10.2.3 Mexico Artificial Intelligence Drug R&D Market Forecast
10.2.4 Brazil Artificial Intelligence Drug R&D Market Forecast
10.3 APAC Artificial Intelligence Drug R&D Forecast by Region (2024-2029)
10.3.1 China Artificial Intelligence Drug R&D Market Forecast
10.3.2 Japan Artificial Intelligence Drug R&D Market Forecast
10.3.3 Korea Artificial Intelligence Drug R&D Market Forecast
10.3.4 Southeast Asia Artificial Intelligence Drug R&D Market Forecast
10.3.5 India Artificial Intelligence Drug R&D Market Forecast
10.3.6 Australia Artificial Intelligence Drug R&D Market Forecast
10.4 Europe Artificial Intelligence Drug R&D Forecast by Country (2024-2029)
10.4.1 Germany Artificial Intelligence Drug R&D Market Forecast
10.4.2 France Artificial Intelligence Drug R&D Market Forecast
10.4.3 UK Artificial Intelligence Drug R&D Market Forecast
10.4.4 Italy Artificial Intelligence Drug R&D Market Forecast
10.4.5 Russia Artificial Intelligence Drug R&D Market Forecast
10.5 Middle East & Africa Artificial Intelligence Drug R&D Forecast by Region (2024-2029)
10.5.1 Egypt Artificial Intelligence Drug R&D Market Forecast
10.5.2 South Africa Artificial Intelligence Drug R&D Market Forecast
10.5.3 Israel Artificial Intelligence Drug R&D Market Forecast
10.5.4 Turkey Artificial Intelligence Drug R&D Market Forecast
10.5.5 GCC Countries Artificial Intelligence Drug R&D Market Forecast
10.6 Global Artificial Intelligence Drug R&D Forecast by Type (2024-2029)
10.7 Global Artificial Intelligence Drug R&D Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 IBM Watson
11.1.1 IBM Watson Company Information
11.1.2 IBM Watson Artificial Intelligence Drug R&D Product Offered
11.1.3 IBM Watson Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 IBM Watson Main Business Overview
11.1.5 IBM Watson Latest Developments
11.2 BioXel
11.2.1 BioXel Company Information
11.2.2 BioXel Artificial Intelligence Drug R&D Product Offered
11.2.3 BioXel Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 BioXel Main Business Overview
11.2.5 BioXel Latest Developments
11.3 Insilico Medicine
11.3.1 Insilico Medicine Company Information
11.3.2 Insilico Medicine Artificial Intelligence Drug R&D Product Offered
11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Insilico Medicine Main Business Overview
11.3.5 Insilico Medicine Latest Developments
11.4 Gatehouse Bio
11.4.1 Gatehouse Bio Company Information
11.4.2 Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Gatehouse Bio Main Business Overview
11.4.5 Gatehouse Bio Latest Developments
11.5 Google DeepMind
11.5.1 Google DeepMind Company Information
11.5.2 Google DeepMind Artificial Intelligence Drug R&D Product Offered
11.5.3 Google DeepMind Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Google DeepMind Main Business Overview
11.5.5 Google DeepMind Latest Developments
11.6 Genpact Cora
11.6.1 Genpact Cora Company Information
11.6.2 Genpact Cora Artificial Intelligence Drug R&D Product Offered
11.6.3 Genpact Cora Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Genpact Cora Main Business Overview
11.6.5 Genpact Cora Latest Developments
11.7 Cyclica Inc
11.7.1 Cyclica Inc Company Information
11.7.2 Cyclica Inc Artificial Intelligence Drug R&D Product Offered
11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Cyclica Inc Main Business Overview
11.7.5 Cyclica Inc Latest Developments
11.8 QuantumBlack
11.8.1 QuantumBlack Company Information
11.8.2 QuantumBlack Artificial Intelligence Drug R&D Product Offered
11.8.3 QuantumBlack Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 QuantumBlack Main Business Overview
11.8.5 QuantumBlack Latest Developments
11.9 Nq Medical
11.9.1 Nq Medical Company Information
11.9.2 Nq Medical Artificial Intelligence Drug R&D Product Offered
11.9.3 Nq Medical Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Nq Medical Main Business Overview
11.9.5 Nq Medical Latest Developments
11.10 Phenomic AI
11.10.1 Phenomic AI Company Information
11.10.2 Phenomic AI Artificial Intelligence Drug R&D Product Offered
11.10.3 Phenomic AI Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Phenomic AI Main Business Overview
11.10.5 Phenomic AI Latest Developments
11.11 Palantir Technologies
11.11.1 Palantir Technologies Company Information
11.11.2 Palantir Technologies Artificial Intelligence Drug R&D Product Offered
11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Palantir Technologies Main Business Overview
11.11.5 Palantir Technologies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artificial Intelligence Drug R&D Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of AI Platfrom
Table 3. Major Players of Analytics Service
Table 4. Artificial Intelligence Drug R&D Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 7. Artificial Intelligence Drug R&D Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 10. Global Artificial Intelligence Drug R&D Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2018-2023)
Table 12. Artificial Intelligence Drug R&D Key Players Head office and Products Offered
Table 13. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Artificial Intelligence Drug R&D Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions (2018-2023)
Table 18. Global Artificial Intelligence Drug R&D Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Artificial Intelligence Drug R&D Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Artificial Intelligence Drug R&D Market Size Market Share by Country (2018-2023)
Table 22. Americas Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 24. Americas Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 26. APAC Artificial Intelligence Drug R&D Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region (2018-2023)
Table 28. APAC Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 30. APAC Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 32. Europe Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country (2018-2023)
Table 34. Europe Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 36. Europe Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug R&D
Table 45. Key Market Challenges & Risks of Artificial Intelligence Drug R&D
Table 46. Key Industry Trends of Artificial Intelligence Drug R&D
Table 47. Global Artificial Intelligence Drug R&D Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. IBM Watson Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 52. IBM Watson Artificial Intelligence Drug R&D Product Offered
Table 53. IBM Watson Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. IBM Watson Main Business
Table 55. IBM Watson Latest Developments
Table 56. BioXel Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 57. BioXel Artificial Intelligence Drug R&D Product Offered
Table 58. BioXel Main Business
Table 59. BioXel Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. BioXel Latest Developments
Table 61. Insilico Medicine Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 62. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
Table 63. Insilico Medicine Main Business
Table 64. Insilico Medicine Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Insilico Medicine Latest Developments
Table 66. Gatehouse Bio Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 67. Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
Table 68. Gatehouse Bio Main Business
Table 69. Gatehouse Bio Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Gatehouse Bio Latest Developments
Table 71. Google DeepMind Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 72. Google DeepMind Artificial Intelligence Drug R&D Product Offered
Table 73. Google DeepMind Main Business
Table 74. Google DeepMind Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Google DeepMind Latest Developments
Table 76. Genpact Cora Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 77. Genpact Cora Artificial Intelligence Drug R&D Product Offered
Table 78. Genpact Cora Main Business
Table 79. Genpact Cora Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Genpact Cora Latest Developments
Table 81. Cyclica Inc Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 82. Cyclica Inc Artificial Intelligence Drug R&D Product Offered
Table 83. Cyclica Inc Main Business
Table 84. Cyclica Inc Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Cyclica Inc Latest Developments
Table 86. QuantumBlack Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 87. QuantumBlack Artificial Intelligence Drug R&D Product Offered
Table 88. QuantumBlack Main Business
Table 89. QuantumBlack Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. QuantumBlack Latest Developments
Table 91. Nq Medical Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 92. Nq Medical Artificial Intelligence Drug R&D Product Offered
Table 93. Nq Medical Main Business
Table 94. Nq Medical Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Nq Medical Latest Developments
Table 96. Phenomic AI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 97. Phenomic AI Artificial Intelligence Drug R&D Product Offered
Table 98. Phenomic AI Main Business
Table 99. Phenomic AI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Phenomic AI Latest Developments
Table 101. Palantir Technologies Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 102. Palantir Technologies Artificial Intelligence Drug R&D Product Offered
Table 103. Palantir Technologies Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Palantir Technologies Main Business
Table 105. Palantir Technologies Latest Developments
Table 1. Artificial Intelligence Drug R&D Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of AI Platfrom
Table 3. Major Players of Analytics Service
Table 4. Artificial Intelligence Drug R&D Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 7. Artificial Intelligence Drug R&D Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 10. Global Artificial Intelligence Drug R&D Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Artificial Intelligence Drug R&D Revenue Market Share by Player (2018-2023)
Table 12. Artificial Intelligence Drug R&D Key Players Head office and Products Offered
Table 13. Artificial Intelligence Drug R&D Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Artificial Intelligence Drug R&D Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions (2018-2023)
Table 18. Global Artificial Intelligence Drug R&D Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Artificial Intelligence Drug R&D Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Artificial Intelligence Drug R&D Market Size Market Share by Country (2018-2023)
Table 22. Americas Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 24. Americas Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 26. APAC Artificial Intelligence Drug R&D Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region (2018-2023)
Table 28. APAC Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 30. APAC Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 32. Europe Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country (2018-2023)
Table 34. Europe Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 36. Europe Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Artificial Intelligence Drug R&D
Table 45. Key Market Challenges & Risks of Artificial Intelligence Drug R&D
Table 46. Key Industry Trends of Artificial Intelligence Drug R&D
Table 47. Global Artificial Intelligence Drug R&D Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Artificial Intelligence Drug R&D Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Artificial Intelligence Drug R&D Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. IBM Watson Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 52. IBM Watson Artificial Intelligence Drug R&D Product Offered
Table 53. IBM Watson Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. IBM Watson Main Business
Table 55. IBM Watson Latest Developments
Table 56. BioXel Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 57. BioXel Artificial Intelligence Drug R&D Product Offered
Table 58. BioXel Main Business
Table 59. BioXel Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. BioXel Latest Developments
Table 61. Insilico Medicine Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 62. Insilico Medicine Artificial Intelligence Drug R&D Product Offered
Table 63. Insilico Medicine Main Business
Table 64. Insilico Medicine Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Insilico Medicine Latest Developments
Table 66. Gatehouse Bio Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 67. Gatehouse Bio Artificial Intelligence Drug R&D Product Offered
Table 68. Gatehouse Bio Main Business
Table 69. Gatehouse Bio Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Gatehouse Bio Latest Developments
Table 71. Google DeepMind Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 72. Google DeepMind Artificial Intelligence Drug R&D Product Offered
Table 73. Google DeepMind Main Business
Table 74. Google DeepMind Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Google DeepMind Latest Developments
Table 76. Genpact Cora Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 77. Genpact Cora Artificial Intelligence Drug R&D Product Offered
Table 78. Genpact Cora Main Business
Table 79. Genpact Cora Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Genpact Cora Latest Developments
Table 81. Cyclica Inc Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 82. Cyclica Inc Artificial Intelligence Drug R&D Product Offered
Table 83. Cyclica Inc Main Business
Table 84. Cyclica Inc Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Cyclica Inc Latest Developments
Table 86. QuantumBlack Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 87. QuantumBlack Artificial Intelligence Drug R&D Product Offered
Table 88. QuantumBlack Main Business
Table 89. QuantumBlack Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. QuantumBlack Latest Developments
Table 91. Nq Medical Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 92. Nq Medical Artificial Intelligence Drug R&D Product Offered
Table 93. Nq Medical Main Business
Table 94. Nq Medical Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Nq Medical Latest Developments
Table 96. Phenomic AI Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 97. Phenomic AI Artificial Intelligence Drug R&D Product Offered
Table 98. Phenomic AI Main Business
Table 99. Phenomic AI Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Phenomic AI Latest Developments
Table 101. Palantir Technologies Details, Company Type, Artificial Intelligence Drug R&D Area Served and Its Competitors
Table 102. Palantir Technologies Artificial Intelligence Drug R&D Product Offered
Table 103. Palantir Technologies Artificial Intelligence Drug R&D Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Palantir Technologies Main Business
Table 105. Palantir Technologies Latest Developments
LIST OF FIGURES
Figure 1. Artificial Intelligence Drug R&D Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence Drug R&D Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Artificial Intelligence Drug R&D Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2022)
Figure 8. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Type in 2022
Figure 10. Artificial Intelligence Drug R&D in Drug Discovery
Figure 11. Global Artificial Intelligence Drug R&D Market: Drug Discovery (2018-2023) & ($ Millions)
Figure 12. Artificial Intelligence Drug R&D in Precision Medicine
Figure 13. Global Artificial Intelligence Drug R&D Market: Precision Medicine (2018-2023) & ($ Millions)
Figure 14. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2022
Figure 15. Global Artificial Intelligence Drug R&D Revenue Market Share by Player in 2022
Figure 16. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Artificial Intelligence Drug R&D Market Size 2018-2023 ($ Millions)
Figure 18. APAC Artificial Intelligence Drug R&D Market Size 2018-2023 ($ Millions)
Figure 19. Europe Artificial Intelligence Drug R&D Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2018-2023 ($ Millions)
Figure 21. Americas Artificial Intelligence Drug R&D Value Market Share by Country in 2022
Figure 22. United States Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region in 2022
Figure 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type in 2022
Figure 28. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application in 2022
Figure 29. China Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country in 2022
Figure 36. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Figure 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Figure 38. Germany Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 52. APAC Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 53. Europe Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 55. United States Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 56. Canada Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 59. China Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 60. Japan Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 61. Korea Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 63. India Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 64. Australia Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 65. Germany Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 66. France Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 67. UK Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 68. Italy Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 69. Russia Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 70. Spain Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 73. Israel Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 76. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Artificial Intelligence Drug R&D Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artificial Intelligence Drug R&D Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Artificial Intelligence Drug R&D Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2022)
Figure 8. Artificial Intelligence Drug R&D Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Artificial Intelligence Drug R&D Market Size Market Share by Type in 2022
Figure 10. Artificial Intelligence Drug R&D in Drug Discovery
Figure 11. Global Artificial Intelligence Drug R&D Market: Drug Discovery (2018-2023) & ($ Millions)
Figure 12. Artificial Intelligence Drug R&D in Precision Medicine
Figure 13. Global Artificial Intelligence Drug R&D Market: Precision Medicine (2018-2023) & ($ Millions)
Figure 14. Global Artificial Intelligence Drug R&D Market Size Market Share by Application in 2022
Figure 15. Global Artificial Intelligence Drug R&D Revenue Market Share by Player in 2022
Figure 16. Global Artificial Intelligence Drug R&D Market Size Market Share by Regions (2018-2023)
Figure 17. Americas Artificial Intelligence Drug R&D Market Size 2018-2023 ($ Millions)
Figure 18. APAC Artificial Intelligence Drug R&D Market Size 2018-2023 ($ Millions)
Figure 19. Europe Artificial Intelligence Drug R&D Market Size 2018-2023 ($ Millions)
Figure 20. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2018-2023 ($ Millions)
Figure 21. Americas Artificial Intelligence Drug R&D Value Market Share by Country in 2022
Figure 22. United States Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 23. Canada Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 24. Mexico Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 25. Brazil Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 26. APAC Artificial Intelligence Drug R&D Market Size Market Share by Region in 2022
Figure 27. APAC Artificial Intelligence Drug R&D Market Size Market Share by Type in 2022
Figure 28. APAC Artificial Intelligence Drug R&D Market Size Market Share by Application in 2022
Figure 29. China Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 30. Japan Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 31. Korea Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 32. Southeast Asia Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 33. India Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 34. Australia Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 35. Europe Artificial Intelligence Drug R&D Market Size Market Share by Country in 2022
Figure 36. Europe Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Figure 37. Europe Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Figure 38. Germany Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 39. France Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 40. UK Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 41. Italy Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 42. Russia Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Region (2018-2023)
Figure 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Type (2018-2023)
Figure 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size Market Share by Application (2018-2023)
Figure 46. Egypt Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 47. South Africa Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 48. Israel Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 49. Turkey Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 50. GCC Country Artificial Intelligence Drug R&D Market Size Growth 2018-2023 ($ Millions)
Figure 51. Americas Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 52. APAC Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 53. Europe Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 54. Middle East & Africa Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 55. United States Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 56. Canada Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 57. Mexico Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 58. Brazil Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 59. China Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 60. Japan Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 61. Korea Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 62. Southeast Asia Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 63. India Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 64. Australia Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 65. Germany Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 66. France Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 67. UK Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 68. Italy Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 69. Russia Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 70. Spain Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 71. Egypt Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 72. South Africa Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 73. Israel Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 74. Turkey Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 75. GCC Countries Artificial Intelligence Drug R&D Market Size 2024-2029 ($ Millions)
Figure 76. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Type (2024-2029)
Figure 77. Global Artificial Intelligence Drug R&D Market Size Market Share Forecast by Application (2024-2029)
